Pathogen surface glycans and lectins

Pathogen surface lectins and carbohydrate-binding structures are essential mediators of the initial stages of infection across viruses, bacteria, and fungi. These molecules, which include bacterial adhesins like FimH and viral proteins like hemagglutinin, recognize and bind to specific sugar sequences on host cell membranes to facilitate attachment and entry (Sharon, 2006, PMID: 16461021). By serving as the primary "docking" mechanism, these structures are pivotal for colonization and subsequent tissue invasion (Varki et al., Essentials of Glycobiology). In therapeutic contexts, they are targeted by glycomimetics and anti-adhesive drugs designed to block these interactions and prevent the onset of disease (Imberty & Varrot, 2008, PMID: 18341574). Additionally, many vaccines utilize these surface carbohydrates or their associated proteins to elicit a protective immune response (Karlsson, 1995, PMID: 7598437). Despite their potential, the structural diversity and high mutation rates of these pathogen components pose significant hurdles for the development of universal inhibitors. Furthermore, the specificity of these interactions often dictates the host range and tissue tropism of the pathogen. Research into these structures continues to inform the design of novel anti-infectives that aim to bypass traditional antibiotic resistance mechanisms.

Other names

Pathogen surface lectins and carbohydrate-binding structures on viruses, bacteria, and fungiMicrobial adhesinsPathogen-associated molecular patterns (PAMPs)HemagglutininsFimbriaeMicrobial surface components recognizing adhesive matrix molecules (MSCRAMMs)Glycoconjugates

Competitive inhibition of microbial adhesion to host cells by blocking lectin-carbohydrate interactions or neutralizing surface glycans.